“I first came to the VBC in 2006 with the intention of staying only three or four years. Nine years later I am still here - the campus just keeps getting better!”
Peggy Stolt-Bergner, Protein Technologies
“VBC - where top expertise and cutting edge scientific infrastructure meets outstanding research and a great atmosphere.”
Jakub Jez, Plant Sciences Facility Head
“The Campus VBC is probably the most vibrant research site in Austria, so anyone interested in research would want to be here.”
Kareem Elsayad, Core Facility Head
“VBCF provides state-of-the-art equipment and dedicated experts. We help you to push your research further.”
Sylvia Badurek, Behavior Assistant at Preclinical Phenotyping Facility
Who We Are
The Vienna BioCenter Core Facilities GmbH (VBCF) is a publicly funded non-profit research institute, situated at the Vienna Biocenter.
We offer access to state-of-the-art research infrastructure and scientific services. Our customers are academic research institutions and companies in the field of Life Sciences.
VBCF is open to all forms of scientific collaborations.
We offer cutting edge infrastructure and scientific services to enable our customers to compete at the forefront of science.
Passion for technology and science, continuous training and lifelong learning are what make VBCF staff the highly qualified experts we need to develop and operate our scientific infrastructure to the satisfaction of our customers.
We constantly scout for new and emerging technologies that can better address the research questions of our customers and aim for joint exploration.
We contribute to the most effective and efficient usage of public and private research funds by providing high-quality service and economies of scale through centralization.
VBCF acts as a communication platform and a joint repository of expertise. Technical knowledge and skills are preserved when researchers leave the Vienna Biocenter and are forwarded to the next generation of researchers.
We cooperate with other providers of research infrastructure to make technologies beyond our own portfolio accessible and to improve the quality of our services through benchmarking.
The Vienna Biocenter Core Facilities GmbH (VBCF) is a publicly funded non-profit research institute, situated at the Vienna Biocenter. VBCF was founded in 2010 as a limited liability company (GmbH) according to Austrian law. VBCF’s stakeholders are:
- Campus Vienna Biocenter Association (50%)
- Max F. Perutz Laboratories GmbH (25%)
- IMBA – Institute of Molecular Biotechnology (15%)
- GMI – Gregor Mendel Institute of Molecular Plant Biology (10%)
The operation of VBCF is funded by the Federal Ministry of Science, Research and Economy (bm.wfw) and the City of Vienna, by fees charged for delivered services and by additional research grants.
VBCF operates 11 scientific core facilities and the shared Child Care Center of the Vienna Biocenter as shown in the organization chart below.
Andreas Tiran took up his appointment as Managing Director of the VBCF in January 2011. He has extensive previous experience both as a researcher as well as a manager of scientific infrastructure.
|since 2011||Managing Director of Vienna Biocenter Core Facilities GmbH (VBCF), Vienna Biocenter, Austria|
|2004-2010||Director of the Center for Medical Research (ZMF), Medical University of Graz, Austria|
|2001-2004||Department Head at the Clinical Institute of Medical and Chemical Laboratory Diagnostics, University of Graz, Austria|
|2001||Associate Professor of Laboratory Medicine, University of Graz, Austria|
|1996-2001||Senior physician, deputy head, Department of Laboratory Medicine, University of Graz, Austria|
|1995||Board Certification Medical and Chemical Laboratory Diagnostic|
|1994-1996||Postdoc at the Department of Clinical Immunology, University Hospital of Groningen, The Netherlands|
|1989-1994||Resident at the Department of Internal Medicine, University of Graz, Austria|
|1982-1988||School of Medicine, University of Graz|
Authorized Representative of VBCF
Peggy Stolt-Bergner is Deputy Director and supports the Managing Director in the running of the institute.
|since 2014||Authorized Representative of VBCF|
|since 2011||Head of VBCF Protein Technologies Facility|
|2006-2011||IMP Fellow, Research Institute of Molecular Pathology|
|2004-2006||Postdoctoral Fellow, Max Planck Institute of Biophysics,|
|1999-2004||PhD, Biochemistry and Molecular Pharmacology, Harvard Medical School|
Barbara Miksch started at the VBCF from the very beginning in 2011 and is responsible for office administration, personnel administration and also external communications.
phone: +43 1 796 23 24 7000
Anastasia Manina joined the VBCF Administration in October 2014 as a controller. Her former international work experience is the perfect prerequisite for looking after the VBCF budget.
phone: +43 1 796 23 24 7011
Lada Fialova joined VBCF in March 2015 as grant manager. Her responsibility is to support and facilitate search for grant opportunities, grant applications, and grant management.
phone: +43 1 796 23 24 7013
Strategic Information Management
The Strategic Information Management (SIM) facility is responsible for a common VBCF IT strategy and centralizes the most important IT tasks of the VBCF. The goal of this facility is to concentrate, merge and plan all IT requirements of the VBVF and setup a service oriented architecture which facilitates the flow of information between the VBCF facilities and administration.
Thomas Micheler is head of Strategic Information Management (SIM) facility since summer 2013. He is responsible for a comprehensive IT strategy and IT controlling for the VBCF.
phone: +43 1 796 23 24 7023
Jan Sladek joined the Strategic Information Management (SIM) facility as software engineer in November 2013. He analyzes IT related requirements and develops/maintains VBCF wide information systems.
phone: +43 1 796 23 24 7228
VBCF has institutional collaborations with national and international research institutions, universities and other organizations with the following goals:
- Initiation of joint research projects
- Facilitation of staff exchange and development of joint training programs
- Improved access to cutting-edge technologies through resource sharing
Core For Life
Core for Life is an excellence initiative of six leading European core facility organizations. The common intention of the members of Core For Life is to collaborate in organizational and operational aspects of core facility management and scientific support of life science research. The Core For Life alliance envisions exploring and using the potential of bundling core facility expertise across institutions and countries.
Interview: Nature Med. 2013, 19, 802
NGS-Platform in Vienna
Next-generation sequencing technology is rapidly evolving and transforming both basic biological science and biomedicine. In order to remain competitive, research organizations in Vienna need to actively invest in this technology. The main goal of the proposed Joint Technology Platform for Next Generation Sequencing in Vienna is to avoid unnecessary overlaps and invest into the newest NGS technologies and equipment in a coordinated and cost-efficient way.
MRI-Platform in Vienna
Since 2013 the VBCF, the AIT Austrian Institute of Technology, the University of Veterinary Medicine and the Medical University of Vienna are collaborating to create a translational research platform for preclinical MRI imaging with the best technical, financial and scientific solutions. Through the collaboration of the most experienced scientific institutions in preclinical imaging in the area of Vienna, we aim to intensify MR research and explore the potential of synergetic effects.
Cutting-edge and innovative imaging technologies are revolutionizing the life sciences. Recent developments enable scientists to visualize and thereby better understand the processes that govern life and disease in cells and organisms. Euro-BioImaging is a research infrastructure project of the ESFRI Roadmap. It aims at creating a pan-European network of advanced imaging facilities that provide open access to advanced imaging technology for all European life scientists. The current VBCF initiative aims at the establishment of a EuroBioImaging node in Vienna by joining forces with universities and other research institutions.
New platform for future integration into EuroBioImaging created, read more here.
Both VBCF and ISTA, the Institute of Science and Technology Austria, have committed themselves to coordinate the purchase of expensive instruments, to increase capacity usage and to bundle core facility expertise across the institutions. In particular VBCF and ISTA will join forces in providing access to state-of-the-art electron microscopy to their research groups.
In 2012, VBCF established a collaboration with AGES, the Austrian Agency for Health and Food Safety. Both institutions operate large-scale plant growth facilities with complementary technical specifications. The goal of the collaboration is the realization of research and development projects in life science by mutual use of technical scientific infrastructure, personnel, know-how, and operating resources.
CEITEC is a scientific centre in the fields of life sciences, advanced materials and technologies whose aim is to establish itself as a recognized centre for basic as well as applied research. CEITEC offers a state-of-the-art infrastructure and great conditions to employ excellent researchers. It is a consortium whose partners include the most prominent universities and research institutes in Brno, Czech Republic: Masaryk University, Brno University of Technology, Mendel University in Brno, University of Veterinary and Pharmaceutical Sciences in Brno, Veterinary Research Institute and Institute of Physics of Materials of the Academy of Sciences of the Czech Republic. CEITEC works closely with the Region of South Moravia and the City of Brno to help increase local innovative capacity.
Basic overview: 6 partners, 7 research programs, 61 research groups, 557 researchers (2015), 25.000 m2 of new laboratories, 10 core facilities